G-7 nations gather to pledge 1B vaccine doses for world

Friday, June 11, 2021 | Zeke Miller, Aamer Madhani And Jill Lawless, Associated Press


US President Joe Biden, right, talks with Britain's Prime Minister Boris Johnson, during their meeting ahead of the G7 summit in Cornwall, Britain, Thursday June 10, 2021. (Toby Melville/Pool Photo via AP)

CARBIS BAY, England (AP) — Leaders from the Group of Seven industrialized nations are set to commit at their summit to sharing at least 1 billion coronavirus shots with struggling countries around the world — half the doses coming from the U.S. and 100 million from the U.K.

Vaccine sharing commitments from U.S. President Joe Biden and British Prime Minister Boris Johnson set the stage for the G-7 meeting in southwest England, where leaders will pivot Friday from opening greetings and a “family photo” directly into a session on “Building Back Better From COVID-19.”

“We’re going to help lead the world out of this pandemic working alongside our global partners,” Biden said. The G-7 also includes Canada, France, Germany, Italy and Japan.

The leaders hope the meeting in the resort of Carbis Bay will also energize the global economy. On Friday, they are set to formally embrace a global minimum tax of at least 15% on corporations, following an agreement reached a week ago by their finance ministers. The minimum is meant to stop companies from using tax havens and other tools to avoid taxes.

It represents a potential win for the Biden administration, which has proposed a global minimum tax as a way to pay for infrastructure projects, in addition to creating an alternative that could remove some European countries’ digital services taxes that largely hit U.S. tech firms.

For Johnson, the first G-7 summit in two years — last year’s was scuttled by the pandemic — is a chance to set out his vision of a post-Brexit “Global Britain” as a midsized country with an outsized role in international problem-solving.

It’s also an opportunity to underscore the U.K-U.S. bond, an alliance often called the “special relationship” — but that Johnson said he prefers to call the “indestructible relationship.”

The official summit business starts Friday, with the customary formal greeting and a socially distanced group photo. Later the leaders will meet Queen Elizabeth II and other senior royals at the Eden Project, a lush, domed eco-tourism site built in a former quarry.

The G-7 leaders have faced mounting pressure to outline their global vaccine-sharing plans, especially as inequities in supply around the world have become more pronounced. In the U.S., there is a large vaccine stockpile and the demand for shots has dropped precipitously in recent weeks.

Biden said the U.S. will donate 500 million COVID-19 vaccine doses and previewed a coordinated effort by the advanced economies to make vaccination widely and speedily available everywhere. The commitment was on top of 80 million doses Biden has already pledged to donate by the end of June.

Johnson, for his part, said the first 5 million U.K. doses would be shared in the coming weeks, with the remainder coming over the next year. He said he expected the G-7 to commit to 1 billion doses in all.

“At the G-7 Summit I hope my fellow leaders will make similar pledges so that, together, we can vaccinate the world by the end of next year and build back better from coronavirus," Johnson said in a statement, referencing a slogan that he and Biden have both used.

French President Emmanuel Macron welcomed the U.S. commitment and said Europe should do the same. He said France would share at least 30 million doses globally by year's end.

Biden predicted the U.S. doses and the overall G-7 commitment would “supercharge” the global vaccination campaign, adding that the U.S. doses come with no strings attached.

The U.S. commitment is to buy and donate 500 million Pfizer doses for distribution through the global COVAX alliance to 92 lower-income countries and the African Union, bringing the first steady supply of mRNA vaccine to the countries that need it most.

Biden said the U.S.-manufactured doses will be shipped starting in August, with the goal of distributing 200 million by the end of the year. The remaining 300 million doses would be shipped in the first half of 2022. A price tag for the doses was not released, but the U.S. is now set to be COVAX's largest vaccine donor in addition to its single largest funder with a $4 billion commitment.

Humanitarian workers welcomed the donation — but said the world needs more doses and they were hoping they would arrive sooner. Grand statements and promises need to be met with detailed plans backed by timelines for delivery, starting immediately.

“If we have a stop-start supply or if we store all the supply up for the end of the year, it’s very hard for low-income countries with quite fragile health care systems to then really be able to get those vaccines off the tarmac and into the arms of health care workers," said Lily Caprani, the head of COVID-19 vaccine advocacy at UNICEF. “We want a coordinated, time-bound, ambitious commitment starting from June and charting the course for the rest of the year.”

The global COVAX alliance has faced a slow start to its vaccination campaign, as richer nations have locked up billions of doses through contracts directly with drug manufacturers. The alliance has distributed just 81 million doses globally and parts of the world, particularly in Africa, remain vaccine deserts.

So far, among the G-7 countries, only France has begun shipping vaccines through COVAX, according one of the initiative's leaders, vaccine alliance Gavi. France has delivered a total of 628,800 doses to seven African countries — with Senegal, a former French colony, receiving about 30% of that total.

Biden said Thursday that some of the 80 million doses the U.S. had previously committed to donating — some of them outside of COVAX — were already shipping. The U.S. has also given a few million vaccines to neighbors Mexico and Canada.

Biden’s latest move, officials said, was meant to ensure a substantial amount of manufacturing capacity remains open to the wealthy nations. Just last month, the European Commission signed an agreement to purchase as many as 1.8 billion Pfizer doses in the next two years, a significant share of the company’s upcoming production — though the bloc reserved the right to donate some of its doses to COVAX.

White House officials said the ramped-up distribution program fits a theme Biden plans to hit frequently during his week in Europe: that Western democracies, and not authoritarian states, can deliver the most good for the world.

China and Russia have shared their domestically produced vaccines with some needy countries, often with hidden strings attached. U.S. national security adviser Jake Sullivan said Biden “does want to show — rallying the rest of the world’s democracies — that democracies are the countries that can best deliver solutions for people everywhere.”

___

Miller reported from Washington, Lawless from Falmouth, England. Associated Press writers Danica Kirka in Falmouth, England; Sylvie Corbet in Paris; Jamey Keaten in Geneva; and Jonathan Lemire in Plymouth, England, contributed to this report.

Featured Article: How Do Front-End Loads Impact an Investment?


7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)1.9$38.81flat4.02%19.80Hold$40.43
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.